Controversy in use of mannitol in head injury

Abstract

The most commonly used drug in the patients of severe head injury is mannitol. The drug is classified pharmacologically as osmotic-diuretic but its mechanism of action in decreasing intracranial pressure is multi-factorial. Despite having dramatic results in the management of head injury patients the drug is still facing many controversies ranging from mechanism of action to the efficacy, especially is the light of evidence based medicine.

Keywords

head injury - mannitol

• References

• 1 Beks JWF, ter Weeme C. The influence of urea and mannitol on increased intraventricular pressure in cold-induced cerebral edema. Acta Neurochir (Wien) 16 1967; 97-107
• 2 Shenkin HA, Goluboff B, Haft H. The use of mannitol for the reduction of intracranial pressure in intracranial injury. J Neurosurg 19 1962; 897-901
• 3 Wise BL, Chater N. The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebrospinal fluid pressure. J Neurosurg 19 1962; 1038-1043
• 4 Rosenberg GA, Barrett J, Estrada E, Brayer J, Kyner WT. Selective effect of mannitol-induced hyperosmolarity on brain interstitial fluid and water content in white matter. Metab Brain Dis 03 1988; 217-227
• 5 Cottrell JE, Robustelli A, Post K, Turndorf H. Furosemideand mannitol-induced changes in ICP and serum osmolarity and electrolytes. Anesthesiology 47 1977; 28-30
• 6 Reed DJ, Woodbury DM. Effect of hypertonic urea on cerebrospinal fluid pressure and brain volume. J Physiol (Lond) 164 1962; 252-264
• 7 Takagi H, Saitoh T, Kitahara T, Morii S, Ohwada T, Yada K. The mechanism of ICP reducing effect of mannitol. in Ishii S, Nagai H, Brock M. (eds): Intracranial Pressure V. 1983. Springer-Verlag; New York: 729-733
• 8 Albright AL, Latchaw RE, Robinson AG. Intracranial and systemic effects of osmotic and oncotic therapy in experimental cerebral edema. J Neurosurg 60 1984; 481-489
• 9 Hartwell Richard C, Sutton Leslie N. Mannitol, intracranial pressure, and vasogenic edema. Neurosurgery 32 1993; 444-450
• 10 Kirkpatrick Peter J, Smielewski Piotr, Piechnik Stefan, Pickard John, Czosnyka Marek. Early effects of mannitol in patients with head injuries assessed using bedside multimodality monitoring. Neurosurgery 39 1996; 714-721
• 11 Muizelaar JP, Lutz HA, Becker DP. Effects of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head injured patients. J Neurosurg 61 1984; 700-706
• 12 Rosner MJ, Coley I. Cerebral perfusion pressure: A hemodynamic mechanism of mannitol and the postmannitol hemogram. Neurosurgery 02 1987; 147
• 13 Wakai A, Roberts I, Schierhout G. Mannitol for acute traumatic brain injury. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD001049. DOI: 10.1002/14651858.CD001049.pub4.
• 14 Sayre MR, Daily SW, Stern SA, Storer DL, van Loveren HR, Hurst JD. Out-of-hospital administration of mannitol does not change systolic blood pressure. Academic Emergency Medicine 03 1996; 840-848
• 15 Schwartz ML, Tator CH, Rowed DW, Reid SR, Meguro K, Andrews DF. The University of Toronto head injury treatment study: a prospective, randomized comparison of pentobarbital and mannitol. Can J Neurol Sci 11 1984; 434-440
• 16 Fortune JB, Feustel PJ, Graca I, Hasselbarth J, Kuehler DH. Effect of hyperventilation, mannitol, and ventriculostomy drainage on cerebral blood-flow after head-injury. J Trauma-Inj Inf Crit Care 39 1995; 1091-1099
• 17 Becker DP, Miller JD, Ward JD. et al The outcome from severe head injury with early diagnosis and intensive management. J Neurosurg 47 1977; 491
• 18 Cruz J. On-line monitoring of global cerebral hypoxia in acute brain injury: Relationship to intracranial hypertension. J Neurosurg 79 1993; 228-233
• 19 Freshman SP, Battistella FD, Matteucci M. et al Hypertonic saline (7.5%) versus mannitol: A comparison for treatment of acute head injuries. J Trauma 35 1993; 344-348
• 20 Berger S, Schurer L, Hartl R. et al 7.2% NaCl/10% dextran 60 versus 20% mannitol for treatment of intracranial hypertension. Acta Neurochir 60 Suppl 1994; 494-498
• 21 Vialet R, Albanese J, Thomachot L, Antonini F, Bourgouin A, Alliez B. et al Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med 31 2003; 1683-1687
• 22 Suarez JI, Qureshi AI, Bhardwaj A. et al Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 26 1998; 1118-1122
• 23 Paczynski RP. Osmotherapy. Crit Care Clin 13 1997; 105-129
• 24 Ghajar J, Hariri RJ, Narayan RK. et al Survey of critical care management of comatose, head-injured patients in the United States. Crit Care Med 23 1995; 560-567
• 25 Jeevaratnam DR, Menon DK. Survey of intensive care of severely head injured patients in the United Kingdom. BMJ 312 1996; 994-997